Aegis Reiterates "Buy" Rating for Catalyst Pharmaceutical Partners

Home › Aegis Reiterates "Buy" Rating for Catalyst Pharmaceutical Partners

's stock had its "buy" rating restated by equities research analysts at Aegis in a research note issued to investors on Friday, ARN reports.

05.10	Atlantic Tropical Weather Outlook
05.10	Eastern North Pacific Tropical Weather Outlook
05.10	Hurricane Leslie Graphics
05.10	Hurricane Leslie Forecast Discussion Number 11
05.10	Hurricane Leslie Wind Speed Probabilities Number 11
05.10	Hurricane Leslie Public Advisory Number 11
05.10	Summary for Hurricane Leslie (AT3/AL132024)
05.10	Hurricane Leslie Forecast Advisory Number 11
More »

je.st